Difference between revisions of "Venrock"
(stub) |
m (website) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
|sourcewatch= | |sourcewatch= | ||
|constitutes= | |constitutes= | ||
| − | |logo= | + | |logo=Venrock Logo.png |
|start=1969 | |start=1969 | ||
| − | |description= | + | |owners=Rockefeller family |
| + | |description= [[Rockefeller family]] venture capital firm investing in [[IT]], [[healthcare]] and [[nanotechnology]] | ||
|headquarters=Palo Alto, New York City,Boston | |headquarters=Palo Alto, New York City,Boston | ||
| − | |website= | + | |website=https://www.venrock.com/ |
|founders=Laurance Rockefeller | |founders=Laurance Rockefeller | ||
|num_staff= | |num_staff= | ||
|members= | |members= | ||
}} | }} | ||
| + | '''Venrock''' (a portmanteau of Venture and Rockefeller) is a [[venture capital firm]] formed in 1969 to build upon the successful investing activities of the [[Rockefeller family]] that began in the late 1930s. It has offices in [[Palo Alto, California]], [[New York City]], and [[Boston, Massachusetts]]. | ||
| + | ==History== | ||
| + | Venture capitalist [[Laurance Rockefeller|Laurance S. Rockefeller]] (1910–2004) was the fourth of the six children of [[John D. Rockefeller, Jr.]] In January 1946 he formed Rockefeller Brothers, Inc., one of the first postwar venture-capital operations, starting with a capitalization of $1.5 million. There were eight partners in all, the five brothers and their sister, Abby, and two non family members [[Harper Woodward]] and [[MIT]] scientist, [[Ted Walkowicz]]. In 1969, the firm became known as Venrock.<ref>https://www.forbes.com/sites/kerryadolan/2013/05/09/how-venrock-is-reinventing-itself/#10a1d6831289</ref> Laurance S. Rockefeller became an investor in enterprises based on science and technology. His investment interests included the fields of aviation, [[aerospace]], electronics, high temperature physics, [[composite material]]s, [[optics]], [[lasers]], [[data processing]], [[thermionics]], and [[nuclear power]]. | ||
| + | |||
| + | Venrock closed its seventh fund in July 2014 with 8 partners and its eighth fund in January 2017 with 15 partners, each fund totalling $450 million.<ref name=tc-close>https://techcrunch.com/2017/01/26/venrock-has-raised-450-million-for-its-eight-fund-just-like-its-seventh-fund/</ref><ref>https://www.forbes.com/sites/kerryadolan/2013/05/09/how-venrock-is-reinventing-itself/#59e054781289</ref> | ||
| + | |||
| + | ==Investments== | ||
| + | Venrock invested more than $2.5 billion in more than 440 companies, resulting in 125 [[initial public offering]]s. Venrock focuses its investments on early-stage and start-up companies in information technology, healthcare and emerging technologies. These include: [[Intel]], [[Apple]], [[Check Point|Check Point Software]], [[DoubleClick]].<ref>https://www.venrock.com/portfolio/</ref>. It also has a significant venture in the nascent [[nanotechnology]] field, with early funding of [[Nanosys]] and the nanotech division of [[Du Pont]].<ref>https://www.nytimes.com/2004/03/15/business/technology-bashful-vs-brash-in-the-new-field-of-nanotech.html?_r=0 </ref> Others include [[BioTime]].<ref> http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?TabIndex=2&FilingID=1363847&companyid=11441&ppu=%252fDefault.aspx%253fcompanyid%253d11441%2526amp%253bformtypeID%253d346</ref><ref>http://www.bloomberglink.com/people/michael-d-west-ph-d/</ref> | ||
| + | |||
| + | In the healthcare sector with partners such as Bryan Roberts, Venrock has invested in [[Gilead]], [[athenahealth]], [[Grand Rounds, Inc.|Grand Rounds]], [[HealthSouth Corporation]], [[MedPartners, Inc.]], [[Castlight Health]], Caliper Technologies Corporation, [[Centocor]], [[Geron Corporation|Geron]],<ref>http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?TabIndex=2&FilingID=1363847&companyid=11441&ppu=%252fDefault.aspx%253fcompanyid%253d11441%2526amp%253bformtypeID%253d346</ref> [[senolytic]] startup [[Unity Biotechnology|UNITY Biotechnology]],<ref name="TimmermanUNITY">https://www.forbes.com/sites/luketimmerman/2016/10/27/drugs-for-diseases-of-aging-arch-fidelity-bezos-bet-116m-on-startup-unity-biotech/#1cc916ce7789</ref> Genetics Institute, Idec Pharmaceuticals Corporation, [[Illumina (company)|Illumina]], [[Millennium Pharmaceuticals]], [[Sirna Therapeutics]], and Sugen. | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | + | ||
{{PageCredit | {{PageCredit | ||
Latest revision as of 07:56, 22 March 2022
 Venrock     | |
|---|---|
 | |
| Formation | 1969 |
| Founder | Laurance Rockefeller |
| Headquarters | Palo Alto, New York City, Boston |
| Owners | Rockefeller family |
| Rockefeller family venture capital firm investing in IT, healthcare and nanotechnology | |
Venrock (a portmanteau of Venture and Rockefeller) is a venture capital firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the late 1930s. It has offices in Palo Alto, California, New York City, and Boston, Massachusetts.
History
Venture capitalist Laurance S. Rockefeller (1910–2004) was the fourth of the six children of John D. Rockefeller, Jr. In January 1946 he formed Rockefeller Brothers, Inc., one of the first postwar venture-capital operations, starting with a capitalization of $1.5 million. There were eight partners in all, the five brothers and their sister, Abby, and two non family members Harper Woodward and MIT scientist, Ted Walkowicz. In 1969, the firm became known as Venrock.[1] Laurance S. Rockefeller became an investor in enterprises based on science and technology. His investment interests included the fields of aviation, aerospace, electronics, high temperature physics, composite materials, optics, lasers, data processing, thermionics, and nuclear power.
Venrock closed its seventh fund in July 2014 with 8 partners and its eighth fund in January 2017 with 15 partners, each fund totalling $450 million.[2][3]
Investments
Venrock invested more than $2.5 billion in more than 440 companies, resulting in 125 initial public offerings. Venrock focuses its investments on early-stage and start-up companies in information technology, healthcare and emerging technologies. These include: Intel, Apple, Check Point Software, DoubleClick.[4]. It also has a significant venture in the nascent nanotechnology field, with early funding of Nanosys and the nanotech division of Du Pont.[5] Others include BioTime.[6][7]
In the healthcare sector with partners such as Bryan Roberts, Venrock has invested in Gilead, athenahealth, Grand Rounds, HealthSouth Corporation, MedPartners, Inc., Castlight Health, Caliper Technologies Corporation, Centocor, Geron,[8] senolytic startup UNITY Biotechnology,[9] Genetics Institute, Idec Pharmaceuticals Corporation, Illumina, Millennium Pharmaceuticals, Sirna Therapeutics, and Sugen.
References
- ↑ https://www.forbes.com/sites/kerryadolan/2013/05/09/how-venrock-is-reinventing-itself/#10a1d6831289
- ↑ https://techcrunch.com/2017/01/26/venrock-has-raised-450-million-for-its-eight-fund-just-like-its-seventh-fund/
- ↑ https://www.forbes.com/sites/kerryadolan/2013/05/09/how-venrock-is-reinventing-itself/#59e054781289
- ↑ https://www.venrock.com/portfolio/
- ↑ https://www.nytimes.com/2004/03/15/business/technology-bashful-vs-brash-in-the-new-field-of-nanotech.html?_r=0
- ↑ http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?TabIndex=2&FilingID=1363847&companyid=11441&ppu=%252fDefault.aspx%253fcompanyid%253d11441%2526amp%253bformtypeID%253d346
- ↑ http://www.bloomberglink.com/people/michael-d-west-ph-d/
- ↑ http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?TabIndex=2&FilingID=1363847&companyid=11441&ppu=%252fDefault.aspx%253fcompanyid%253d11441%2526amp%253bformtypeID%253d346
- ↑ https://www.forbes.com/sites/luketimmerman/2016/10/27/drugs-for-diseases-of-aging-arch-fidelity-bezos-bet-116m-on-startup-unity-biotech/#1cc916ce7789
This page imported content from Wikipedia on 03.03.2021.Wikipedia is not affiliated with Wikispooks. Original page source here
